Discovery and Optimization of HKT288, a Cadherin-6-Targeting ADC for the Treatment of Ovarian and Renal Cancers.

Saved in:
Bibliographic Details
Title: Discovery and Optimization of HKT288, a Cadherin-6-Targeting ADC for the Treatment of Ovarian and Renal Cancers.
Authors: Bialucha CU; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts. carl_uli.bialucha@novartis.com., Collins SD; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Li X; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Saxena P; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Zhang X; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Dürr C; Novartis Institutes for Biomedical Research, Novartis Campus, Basel, Switzerland., Lafont B; Novartis Institutes for Biomedical Research, Novartis Campus, Basel, Switzerland., Prieur P; Novartis Institutes for Biomedical Research, Novartis Campus, Basel, Switzerland., Shim Y; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Mosher R; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Lee D; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Ostrom L; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Hu T; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Bilic S; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Rajlic IL; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Capka V; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Jiang W; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Wagner JP; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Elliott G; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Veloso A; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Piel JC; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Flaherty MM; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Mansfield KG; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Meseck EK; Novartis Institutes for Biomedical Research, East Hanover, New Jersey., Rubic-Schneider T; Novartis Institutes for Biomedical Research, Campus Klybeckstrasse, Basel, Switzerland., London AS; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Tschantz WR; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Kurz M; Novartis Pharma AG, Novartis Campus, Basel, Switzerland., Nguyen D; Novartis Pharma, Cambridge, Massachusetts., Bourret A; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Meyer MJ; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Faris JE; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Janatpour MJ; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Chan VW; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Yoder NC; ImmunoGen Inc., Waltham, Massachusetts., Catcott KC; ImmunoGen Inc., Waltham, Massachusetts., McShea MA; ImmunoGen Inc., Waltham, Massachusetts., Sun X; ImmunoGen Inc., Waltham, Massachusetts., Gao H; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Williams J; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Hofmann F; Novartis Institutes for Biomedical Research, Campus Klybeckstrasse, Basel, Switzerland., Engelman JA; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Ettenberg SA; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Sellers WR; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Lees E; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.
Source: Cancer discovery [Cancer Discov] 2017 Sep; Vol. 7 (9), pp. 1030-1045. Date of Electronic Publication: 2017 May 19.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2159-8290
DOI:10.1158/2159-8290.CD-16-1414